Henrik has 25+ years of leadership experience in the biopharmaceutical industry across multiple business models, therapeutic areas, and companies, including past CBO roles at Sapreme Technologies, Promethera BioSciences, and OctoPlus. At OctoPlus, Henrik was instrumental in the transition of the company from a biopharmaceutical R&D service provider to a drug development organization with two proprietary products in clinical trials. As a serial entrepreneur, Henrik co-founded several life science start-ups including Atriva Therapeutics, InScreenEx, DendroPharm and ICA Aesthetic Navigation and supported their growth leading to several trade sales. In total, Henrik has managed around 250 IP-related, transactional, and licensing deals during his career.